Guideline Protocol of Non-Pharmacological Secondary Prevention for Myocardial Infarction_Chinese Journal of Evidence-Based Medicine

Authors：

 LIYan ¹ ^# ,  CHENYao-long ² ^# ,  CHENJing ¹ ,  SHANGHong-cai ³ , YANGKe-hu ² , GUOGui-fang ⁴ , JINYing-hui ¹ , WANGXiao-qin ² , WANG ² , WEIDang ² , YAOLiang ² , XIAOShu-jun ²

1. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;
2. Evidence-Based Medicine Center/Chinese GRADE Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China;
3. Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China;
4. Peking University School of Nursing, Beijing 100191, China;

Corresponding author：

CHENJing, Email: cjshcsyc@126.com; SHANGHong-cai, Email: shanghongcai@Foxmail.com

Keywords：

Myocardial infarction; Guideline; Secondary prevention; Protocol

DOI：

10.7507/1672-2531.20160095

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

For the purposes of promoting the effect of secondary prevention of myocardial infarction, and improving the compliance with myocardial infarction (MI) secondary prevention, a guideline for strengthening patients self-management on non-pharmacological secondary prevention was produced by an multidiscipline team leaded by Chinese Association of Integrative Medicine clinical cardiovascular branch, Lanzhou University Evidence-Based Medicine Center, Peking University School of Nursing, Tianjin University of Traditional Chinese Medicine and Beijing University of Chinese Medicine. This is the first version of patient guideline in China. This paper introduces the main methods, processes and characteristics of the patient guideline development. It will provide reference to future researchers to the development of the patient guideline.

Citation： LIYan, CHENYao-long, CHENJing, SHANGHong-cai, YANGKe-hu, GUOGui-fang, JINYing-hui, WANGXiao-qin, WANG, WEIDang, YAOLiang, XIAOShu-jun. Guideline Protocol of Non-Pharmacological Secondary Prevention for Myocardial Infarction. Chinese Journal of Evidence-Based Medicine, 2016, 16(5): 617-620. doi: 10.7507/1672-2531.20160095 Copy

1.	陈伟伟, 高润霖, 刘力生, 等. 《中国心血管病报告2014》概要. 中国循环杂志, 2015, 30(7): 617-622.
2.	李世军, 李小鹰. 阿司匹林与华法令联合抗凝治疗在急性心肌梗死后二级预防中的地位评价. 医学综述, 2009, 15(13): 1972-1974.
3.	Grover G, Dutta R, Gadpayle AK, et al. Changing patterns of cardiovascular risk factors and heart related sickness in relation with acute myocardial infarction in Delhi, India. J Indian Med Assoc, 2009, 107(9): 636-640.
4.	徐晓峰. 急性心肌梗死的康复与非药物二级预防. 解放军保健医学杂志, 2003, 5(2): 77-79.
5.	许敏, 郭金成, 华琦. 老年急性心肌梗死患者出院后二级预防药物应用现状调查. 中国心血管杂志, 2012, 17(1): 18-22.
6.	中华医学会心血管病分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志, 2015, 43(5): 380-391.
7.	中国医师协会中西医结合医师分会, 中国中西医结合学会心血管病专业委员会等. 2014急性心肌梗死中西医结合诊疗专家共识. 中国中西医结合杂志, 2014, 12(6): 641-645.
8.	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 2007不稳定性心绞痛和非段抬高心肌梗死诊断与治疗指南. 中华心血管病杂志, 2007, 35(4): 295-304.
9.	高晓津, 杨进刚, 杨跃进, 等. 中国急性心肌梗死患者心血管危险因素分析. 中国循环杂志, 2015, 30(3): 206-210.
10.	李湘萍. 对初发急性心肌梗死患者真实体验的质性研究. 护士进修杂志, 2007, 22(22): 2035-2037.
11.	王珊珊, 薛小玲, 杨小芳, 等. 基于时机理论对急性心肌梗死患者家属不同阶段照护体验的质性研究. 中华护理杂志, 2014, 49(9): 1066-1071.
12.	G-I-N PUBLIC. G-I-N PUBLIC Toolkit: Patient and Public Involvement in Guidelines. Available at: http://www.g-i-n.net/document-store/working-groups-documents/g-i-n-public/toolkit/toolkit-combined.pdf/view.
13.	National Comprehensive Cancer Network. NCCN guidelines for patients (version 1.2015) Available at: http://www.nccn.org/patients/guidelines/cancers.aspx#prostate.
14.	Scottish Intercollegiate Guidelines Network. Glaucoma referral and safe discharge: A national clinical guideline (version 1.2015). Available at: http://www.sign.ac.uk/guidelines/fulltext/144/.
15.	Available at: http://www.nccn.org/patients/guidelines/default.aspx.
16.	World Health Organization. WHO handbook for guideline development. 2nd ed. WHO Press, 2014.
17.	Available at: http://www.guideline.gov/about/inclusion-criteria.aspx.
18.	Available at: http://www.agreetrust.org/about-the-agree-enterprise/agree-research-teams/agree-next-steps-consortium.
19.	Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 7: 10.

1. 陈伟伟, 高润霖, 刘力生, 等. 《中国心血管病报告2014》概要. 中国循环杂志, 2015, 30(7): 617-622.
2. 李世军, 李小鹰. 阿司匹林与华法令联合抗凝治疗在急性心肌梗死后二级预防中的地位评价. 医学综述, 2009, 15(13): 1972-1974.
3. Grover G, Dutta R, Gadpayle AK, et al. Changing patterns of cardiovascular risk factors and heart related sickness in relation with acute myocardial infarction in Delhi, India. J Indian Med Assoc, 2009, 107(9): 636-640.
4. 徐晓峰. 急性心肌梗死的康复与非药物二级预防. 解放军保健医学杂志, 2003, 5(2): 77-79.
5. 许敏, 郭金成, 华琦. 老年急性心肌梗死患者出院后二级预防药物应用现状调查. 中国心血管杂志, 2012, 17(1): 18-22.
6. 中华医学会心血管病分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志, 2015, 43(5): 380-391.
7. 中国医师协会中西医结合医师分会, 中国中西医结合学会心血管病专业委员会等. 2014急性心肌梗死中西医结合诊疗专家共识. 中国中西医结合杂志, 2014, 12(6): 641-645.
8. 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 2007不稳定性心绞痛和非段抬高心肌梗死诊断与治疗指南. 中华心血管病杂志, 2007, 35(4): 295-304.
9. 高晓津, 杨进刚, 杨跃进, 等. 中国急性心肌梗死患者心血管危险因素分析. 中国循环杂志, 2015, 30(3): 206-210.
10. 李湘萍. 对初发急性心肌梗死患者真实体验的质性研究. 护士进修杂志, 2007, 22(22): 2035-2037.
11. 王珊珊, 薛小玲, 杨小芳, 等. 基于时机理论对急性心肌梗死患者家属不同阶段照护体验的质性研究. 中华护理杂志, 2014, 49(9): 1066-1071.
12. G-I-N PUBLIC. G-I-N PUBLIC Toolkit: Patient and Public Involvement in Guidelines. Available at: http://www.g-i-n.net/document-store/working-groups-documents/g-i-n-public/toolkit/toolkit-combined.pdf/view.
13. National Comprehensive Cancer Network. NCCN guidelines for patients (version 1.2015) Available at: http://www.nccn.org/patients/guidelines/cancers.aspx#prostate.
14. Scottish Intercollegiate Guidelines Network. Glaucoma referral and safe discharge: A national clinical guideline (version 1.2015). Available at: http://www.sign.ac.uk/guidelines/fulltext/144/.
15. Available at: http://www.nccn.org/patients/guidelines/default.aspx.
16. World Health Organization. WHO handbook for guideline development. 2nd ed. WHO Press, 2014.
17. Available at: http://www.guideline.gov/about/inclusion-criteria.aspx.
18. Available at: http://www.agreetrust.org/about-the-agree-enterprise/agree-research-teams/agree-next-steps-consortium.
19. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 7: 10.

Previous Article
QE or RE? A Bias Adjusted Weighting Procedure for Meta-analysis

Chinese Journal of Evidence-Based Medicine

Guideline Protocol of Non-Pharmacological Secondary Prevention for Myocardial Infarction

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content